Skip Nav Destination
Issues
15 January 2013
-
Cover Image
Cover Image
Confocal immunofluorescent image showing the effects of the polycomb repressor complex 2 inhibitor 3-deazaneplanocin A on tumor cellularity and apoptosis in a xenotransplant model of human head and neck cancer. Immunodeficient mice were injected with a head and neck cancer cell line which was allowed to establish prior to daily treatment with 5 mg/kg DZNep. Tumor tissue has been stained with DAPI to highlight cell nuclei. Green immunofluorescence highlights the human epithelial tumor cells (AEI/III positive) and red fluorescence highlights caspase III positive dying cells. For details, see the article by Gannon and colleagues on page 428 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Statistics in Clinical Cancer Research
Molecular Pathways
Review
Human Cancer Biology
Cancer Therapy: Preclinical
Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies
Yicheng Mao; Georgia Triantafillou; Erin Hertlein; William Towns; Matthew Stefanovski; Xiaokui Mo; David Jarjoura; Mitch Phelps; Guido Marcucci; Ly James Lee; David M. Goldenberg; Robert J. Lee; John C. Byrd; Natarajan Muthusamy
BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
Michelle R. Kuhne; Tanya Mulvey; Blake Belanger; Sharline Chen; Chin Pan; Colin Chong; Fei Cao; Wafa Niekro; Tom Kempe; Karla A. Henning; Lewis J. Cohen; Alan J. Korman; Pina M. Cardarelli
BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice
Chengwen Liu; Weiyi Peng; Chunyu Xu; Yanyan Lou; Minying Zhang; Jennifer A. Wargo; Jie Qing Chen; Haiyan S. Li; Stephanie S. Watowich; Yan Yang; Dennie Tompers Frederick; Zachary A. Cooper; Rina M. Mbofung; Mayra Whittington; Keith T. Flaherty; Scott E. Woodman; Michael A. Davies; Laszlo G. Radvanyi; Willem W. Overwijk; Gregory Lizée; Patrick Hwu
Imaging, Diagnosis, Prognosis
Variation in Precursor Lesions of Pancreatic Cancer among High-Risk Groups
Thomas P. Potjer; Ingrid Schot; Peter Langer; Johannes T. Heverhagen; Martin N.J.M. Wasser; Emily P. Slater; Günter Klöppel; Hans M. Morreau; Bert A. Bonsing; Wouter H. de Vos tot Nederveen Cappel; Mathias Bargello; Thomas M. Gress; Hans F.A. Vasen; Detlef K. Bartsch; on behalf of the Leiden Familial Pancreatic Cancer Group and the FaPaCa registry
Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
Makoto Endo; Hidetaka Yamamoto; Nokitaka Setsu; Kenichi Kohashi; Yusuke Takahashi; Takeaki Ishii; Kei-ichiro Iida; Yoshihiro Matsumoto; Michiyuki Hakozaki; Mikiko Aoki; Hiroshi Iwasaki; Yoh Dobashi; Kenichi Nishiyama; Yukihide Iwamoto; Yoshinao Oda
Cancer Therapy: Clinical
Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
Evan J. Lipson; William H. Sharfman; Charles G. Drake; Ira Wollner; Janis M. Taube; Robert A. Anders; Haiying Xu; Sheng Yao; Alice Pons; Lieping Chen; Drew M. Pardoll; Julie R. Brahmer; Suzanne L. Topalian
Predictive Biomarkers and Personalized Medicine
Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment
Valentina Nardi; Peter M. Sadow; Dejan Juric; Dave Zhao; Arjola K. Cosper; Kristin Bergethon; Vanessa L. Scialabba; Julie M. Batten; Darrell R. Borger; Anthony John Iafrate; Rebecca S. Heist; Donald P. Lawrence; Keith T. Flaherty; Johanna C. Bendell; Daniel Deschler; Yi Li; Lori J. Wirth; Dora Dias-Santagata
Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy
Heather E. Wheeler; Eric R. Gamazon; Claudia Wing; Uchenna O. Njiaju; Chidiamara Njoku; Robert Michael Baldwin; Kouros Owzar; Chen Jiang; Dorothy Watson; Ivo Shterev; Michiaki Kubo; Hitoshi Zembutsu; Eric P. Winer; Clifford A. Hudis; Lawrence N. Shulman; Yusuke Nakamura; Mark J. Ratain; Deanna L. Kroetz; Nancy J. Cox; Mary Eileen Dolan; for the Cancer and Leukemia Group B
CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8
Matthew P. Goetz; Vera J. Suman; Tanya L. Hoskin; Michael Gnant; Martin Filipits; Stephanie L. Safgren; Mary Kuffel; Raimund Jakesz; Margaretha Rudas; Richard Greil; Otto Dietze; Alois Lang; Felix Offner; Carol A. Reynolds; Richard M. Weinshilboum; Matthew M. Ames; James N. Ingle
Retraction
Advertisement